Brett A. Giffin - Feb 20, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Commercial Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 20, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 06:22 PM
Previous filing
Mar 30, 2022
Next filing
Mar 30, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Award $0 +200K $0.00 200K Feb 20, 2022 Common Stock 200K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units vest in three equal annual installments commencing on February 20, 2023.